12 completed, 6 recruiting, 6 unknown, 4 not yet recruiting. 16 Not applicable, 6 Phase 2, 4 Phase 3, 3 Phase 4, 2 Early Phase 1.
Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intravenous Iron in the Management of Drug-resistant Restless Legs syndromeI Ferric Carboxymaltose Injection [Ferinject], Randomization, Questionnaire and Physical Exam - Restless Legs Syndrome (RLS) | Phase 2 | Not yet recruiting | University Hospital, Montpellier | 66 | 2026-10-01 | 2026-09-16 |
| Study of XNW5004 Tablets in Advanced Prostate Cancer XNW5004 1200 mg BID in Combination with Abiraterone plus Prednisone, XNW5004 1200 mg BID in Combination with Docetaxel plus Prednisone, XNW5004 800 mg or 1200 mg (1:1 randomization), PO, BID; Abiraterone 1000 mg PO, taken on an empty stomach at least 1 hour before and at least 2 hours after a meal, QD; plus Prednisone 5 mg PO BID - Advanced Prostate Cancer | Phase 2 | Not yet recruiting | Evopoint Biosciences Inc. | 242 | 2026-07-13 | 2026-07-28 |
| Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial Fibroscan CAP/VTE, Randomization, MRI-PDFF - Non Alcoholic Fatty Liver Disease | Not applicable | Not yet recruiting | University Hospital, Toulouse | 216 | 2026-06-01 | 2026-03-27 |
| Percutaneous Drainage Versus Antibiotic Therapy for Acute Diverticulitis With Abscess. Arm 1 (Control Arm) - Percutaneous drainage plus antibiotics: Image-guided (CT or ultrasound) percutaneous drainage performed within 48 hours of randomization with intravenous bro, Arm 2 (Experimental Arm) - Antibiotics alone: Intravenous broad-spectrum antibiotics: piperacillin-tazobactam 4 g/0.5 g q6h (dosage to be adjusted based on renal function) according to the recent lite - Diverticular Disease of Colon | Not applicable | Not yet recruiting | Azienda Sanitaria di Firenze | 50 | 2026-04-01 | 2026-01-20 |
| BeFlared Versus VBX for FEVAR Randomization - Fenestrated Endovascular Aortic Repair | Not applicable | Recruiting | Medical University of Vienna | 126 | 2026-02-19 | 2026-02-27 |
| The Efficacy of AI-Driven Feces Identification for Bowel Preparation Prior to Colonoscopy A Prospective, Randomized, Evaluator Blind, Parallel Study of the Efficacy of AI-driven feces identifying for the Bowel Preparation Prior to Colonoscopy, educational leaflet without APP - AI App Improves Bowel Preparation Quality for Colonoscopy | Not applicable | Active not recruiting | Fu Jen Catholic University Hospital | 340 | 2025-09-04 | 2026-07-21 |
| Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and Effectiveness Pre-screening Phase, Screenig Phase, Randomization - Soil-Transmitted Helminths | Phase 3 | Recruiting | Insud Pharma | 20000 | 2025-09-01 | 2025-09-15 |
| Study to Compare the Clinical Effectiveness and Cost Utility of an All-in-one Procedure With an At-home Screening Trial Randomization - Neuromodulation, Chronic Pain Patients | Not applicable | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 180 | 2025-06-06 | 2025-07-10 |
| A 3-cohort Randomized Study Evaluating the Role of New Immunotherapeutic Agents and of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Frontline Therapy of Adults With Acute Lymphoblastic Leukemia Randomization + Blinatumomab + chemotherapy, Randomization + Standard frontline T-ALL chemotherapy backbone, Randomization + Isatuximab + Standard frontline T-ALL chemotherapy backbone - Acute Lymphoblastic Leukemia | Phase 2 / Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 1200 | 2025-05-06 | 2026-02-10 |
| Medico-economic Evaluation of Robot-assisted Laparoscopy Compared With Conventional Laparoscopy in Hysterectomy for Endometrial Cancer. Robot-assisted laparoscopy, conventional laparoscopy, Prospective cohort study - Hysterectomies for Low- or Intermediate-risk Endometrial Carcinoma | Not applicable | Recruiting | Rennes University Hospital | 1680 | 2024-09-23 | 2025-09-15 |
| Hair Removal: Intense Pulsed Light Versus Diode Laser Intense Pulsed Light, Diode Laser - Hair Removal | Not applicable | Terminated | University of Nove de Julho | 48 | 2023-11-30 | 2025-08-27 |
| Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 CTx-1301-Dexmethylphenidate 12.5 mg (titration only), CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose), CTx-1301-Dexmethylphenidate 25mg (randomized fixed dose) - ADHD, Attention Deficit Hyperactivity Disorder | Phase 3 | Completed | Cingulate Therapeutics | 103 | 2023-08-01 | 2026-01-22 |
| Clinical Trial to Evaluate the Efficacy and Safety of Codivir® in Addition to Standard Antiretroviral Treatment for HIV Infection in Antiretroviral-naïve Participants ICF, Eligibility Assessment, Demographic data - HIV, HIV Infection | Phase 2 | Recruiting | Code Pharma | 40 | 2023-07-20 | 2024-11-06 |
| An Investigator Initiated, Randomized, Double-blinded, Placebo-controlled Clinical Trial to Evaluate the Safety, Immunogenicity and Efficacy of the Recombinant Two-component COVID-19 Vaccine (CHO Cell) in Adults Aged 18 Years and Older randomized, double-blinded, placebo-controlled - Prevention of COVID-19 Caused by SARS-CoV-2 | Early Phase 1 | Unknown | Yu Qin | 3300 | 2022-12-27 | 2023-01-11 |
| Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome Randomized: 40 mg Paltusotine, Randomized: 80 mg Paltusotine - Carcinoid Syndrome, Carcinoid | Phase 2 | Completed | Crinetics Pharmaceuticals Inc. | 36 | 2022-04-22 | 2026-03-19 |
| Public Support for COVID-19 Test Allocation First Come, First Served, Random, Disadvantaged Priority & Random - Health Equity, COVID-19 | Not applicable | Completed | University of Pennsylvania | 2019 | 2022-01-04 | 2022-01-11 |
| Red and Processed Meat Effects on the Metabolome and Microbiome Randomized, cross-over controlled feeding trial testing a Healthy Eating Index 2015 (HEI-2015) diet with and without red and processed meat - Controlled Feeding Trial, Healthy Eating Index | Not applicable | Completed | Fred Hutchinson Cancer Center | 23 | 2021-11-16 | 2024-09-05 |
| Glutenfree, Gut Microbiota and Metabolic Regulation Randomized, controlled trial (RCT) with parallel arms and double blinded - Celiac Disease | Not applicable | Completed | Oslo Metropolitan University | 30 | 2021-09-01 | 2024-08-12 |
| Comprehensive Prognostic Model: The Study Introduces a Novel Prognostic Model That Incorporates a Wide Range of Clinical and Laboratory Variables, Providing a More Holistic Approach to Predicting Overall Survival in HCC Patients Randomization - Hepatocellular Carcinoma | Completed | Haike Lei | 1053 | 2019-01-01 | 2024-08-13 | |
| Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation NK cells - NK Cell Mediated Immunity | Early Phase 1 | Unknown | Shenzhen Fifth People's Hospital | 10 | 2018-01-01 | 2019-12-06 |
Showing 20 of 31. Sign in to see all of them.
Diabetes Mellitus (2) · Acquired Immunodeficiency Syndrome (1) · Alcohol Drinking (1) · Alcoholism (1) · Attention Deficit Disorder with Hyperactivity (1) · Breast Neoplasms (1) · COVID-19 (1) · Carcinoid Tumor (1) · Carcinoid Tumors, Intestinal (1) · Carcinoma, Hepatocellular (1) · Cardiomyopathy, Dilated (1) · Celiac Disease (1) · Chagas Cardiomyopathy (1) · Chronic Pain (1) · Depression (1)
National Taiwan University Hospital (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Sanitaria di Firenze (1) · Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte (1) · Cingulate Therapeutics (1) · Code Pharma (1) · Crinetics Pharmaceuticals Inc. (1) · Dr. Jean E. Starr, MD (1) · Evopoint Biosciences Inc. (1) · Federal University of Minas Gerais (1) · Fred Hutchinson Cancer Center (1) · Fu Jen Catholic University Hospital (1) · Fundacion Investigacion Interhospitalaria Cardiovascular (1) · Haike Lei (1)
United States (10) · Brazil (4) · France (4) · China (3) · Taiwan (3) · Argentina (1) · Austria (1) · Canada (1) · Ghana (1) · Italy (1) · Kenya (1) · Mexico (1) · Netherlands (1) · Norway (1) · Peru (1)
Alejandro Krolewiecki, MD (1) · Alfonso Frigerio, Dr (1) · Alison M Buttenheim, PhD, MBA (1) · Ann Childress, MD (1) · Christiane Pavani, PhD (1) · Enrico Cerrato, MD (1) · Fernando A Botoni, MD, PhD (1) · Jason Chia-Hsien Cheng (1) · Javier Escaned, MD, PhD (1) · Jean E Starr, MD (1) · Li-Min Huang, MD, PHD (1) · Linn Goldberg, M.D. (1) · Marian L. Neuhouser, PhD, RD (1) · Matt Brams, MD (1) · Mihai Niculescu, PhD (1)
PMID 12507797, PMID 17383291, PMID 17950161, PMID 19701034, PMID 22410137, PMID 25919246, PMID 28526024, PMID 42249955
2015 (1), R21DK128754 (1), U01DE014577 (1)